The Most Widely Implanted LAAM Device Worldwide
Over 700,000 AtriClip devices and more than 20 years of innovation make AtriClip the global leader in Left Atrial Appendage Management (LAAM)
BoxX-NoAF Clinical Trial Now Enrolling
This trial aims to determine if a BoxX surgical ablation and LAA exclusion during planned heart surgery is safe and effective to reduce new-onset Afib in patients without a history of Afib but have risk factors for developing Afib
Introducing the cryoXT™ Probe
The new cryoXT probe harnesses the power of cryoICE® technology for a non-opioid approach to amputation pain management
0
Patients Served with Ablation Worldwide
0
AtriClip Devices Sold Worldwide
U.S. NEWS
AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare Conference
REDUCING GLOBAL AFIB
What is Afib, and how does it affect heart performance?
CAREERS
Interested in joining our mission to reduce the global Afib epidemic?
THERAPY INNOVATION
Post-Operative Pain Management: A non-opioid solution
PM-US-0301U-1027-G
© 2026 Atricure, Inc. All Rights Reserved.
Kathy's Journey with Long-standing Persistent Afib
Duration: 4:45
Is PFA Effective in the Treatment of Persistent and Long Standing Persistent Atrial Fibrillation
Duration: 21:19
Cryo Nerve Block: A Non-Opioid Solution for Post-op Pain Management
Duration: 3:22
Mike's Story: From 10 Years of Afib to Having His Life Back
Duration: 3:39
social media channels to keep updated on the latest at AtriCure.